Rothbaum Amends Iovance Stake Filing

TL;DR

Rothbaum updated his Iovance filing, likely signaling ongoing involvement or strategy adjustments.

AI Summary

Wayne P. Rothbaum, through Quogue Capital LLC, has amended their Schedule 13D filing regarding Iovance Biotherapeutics, Inc. on March 19, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or changes in percentage are not detailed in this excerpt. Rothbaum previously held a significant stake and has been involved in discussions with the company's board.

Why It Matters

Changes in significant shareholder filings like this can signal shifts in investor sentiment or strategy, potentially impacting the stock price of Iovance Biotherapeutics.

Risk Assessment

Risk Level: medium — Amendments to 13D filings by significant shareholders can indicate strategic shifts or potential activism, warranting close monitoring.

Key Players & Entities

• Wayne P. Rothbaum (person) — Filing party and beneficial owner
• Quogue Capital LLC (company) — Filing entity controlled by Wayne P. Rothbaum
• Iovance Biotherapeutics, Inc. (company) — Subject company of the filing
• Lion Biotechnologies, Inc. (company) — Former name of Iovance Biotherapeutics
• Genesis Biopharma, Inc (company) — Former name of Iovance Biotherapeutics
• FREIGHT MANAGEMENT CORP (company) — Former name of Iovance Biotherapeutics

FAQ

Key Financial Figures

• $0.000041666 — Inc. (Name of Issuer) Common Stock, $0.000041666 par value per share (Title of Class o
• $45,750,000 — stered offering for a purchase price of $45,750,000. As a result of the transactions above

Filing Documents

• tm249236d1_sc13da.htm (SC 13D/A) — 33KB
• 0001104659-24-036221.txt ( ) — 35KB

is hereby amended to add the following

Item 3 is hereby amended to add the following:

of the Original Schedule 13D

Item 3 of the Original Schedule 13D On February 20, 2024, Quogue purchased 5,000,000 shares of Common Stock from the Issuer in a registered offering for a purchase price of $45,750,000. As a result of the transactions above, Quogue is the direct beneficial owner of 28,067,333 shares of Common Stock. Quogue is also the owner of 1,932,667 shares of Series B Convertible Preferred Stock, which is excluded from the above Common Stock. Mr. Rothbaum, in his capacity as the sole managing member of Quogue, may be deemed the indirect beneficial owner of the aforementioned securities held by Quogue. The working capital of the Filing Persons was the source of the funds for the purchase of the securities described above. No part of the purchase price of the securities described above was represented by funds or other consideration borrowed or otherwise obtained for the purpose of acquiring, holding, trading or voting the securities described above . Item 5. Interest in Securities of the Issuer

is hereby amended and restated as follows

Item 5 is hereby amended and restated as follows: (a) As more fully described in Item 3 above, each of the Filing Persons is the beneficial owner of 28,067,333 shares of the Issuer’s Common Stock and 1,932,667 shares of Series B Convertible Preferred Stock, representing 11.6% of the Issuer’s shares of Common Stock outstanding. The percentage calculations are based upon 256,135,715 shares of Common Stock, 194 shares of Series A Convertible Preferred Stock and 2,842,158 shares of Series B Convertible Preferred Stock outstanding as of December 31, 2023, based on information provided by the Issuer. (b) By virtue of his status as the sole managing member of Quogue, Mr. Rothbaum may be deemed to share voting and dispositive power with respect to the 28,067,333 shares of the Issuer’s Common Stock beneficially owned by Quogue. Mr. Rothbaum disclaims beneficial ownership of the securities and this report shall not be deemed an admission that Mr. Rothbaum is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein. (c) During the past sixty days prior to the date hereof, the following transactions occurred: Other than as described in Items 3, during the past sixty days prior to the date hereof, the Filing Persons have not engaged in any transaction in the Issuer’s Common Stock. (d) No person, other than Mr. Rothbaum, is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, the shares of Common Stock beneficially owned by Quogue. (e) Not applicable. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: March 19, 2024 Quogue Capital LLC By: /s/ Wayne P. Rothbaum Name: Wayne P. Rothbaum Title: Managing Member Dated: March 19, 2024 /s/ Wayne P. Rothbaum

View Full Filing

View this SC 13D/A filing on SEC EDGAR